Business Details
Emergency
services
Your Trusted Partner for Orphan Drug Commercialization
Anovorx Group is a specialized healthcare solutions provider dedicated exclusively to orphan drugs and rare disease therapies. With over a decade of combined experience from our leadership team, we offer a fully integrated service model encompassing specialty pharmacy, patient services hub, and third-party logistics. Our expertise lies in developing customized programs that address the unique challenges of rare disease management, including insurance navigation, personalized patient care coordination, and streamlined medication distribution.As an industry leader, we maintain VAWD accreditation and comply with 21 CFR Part 205 standards, ensuring the highest levels of quality and safety. Our commitment to excellence is evidenced by 99% patient satisfaction ratings over eight years and successful partnerships with leading pharmaceutical companies in over 10 rare disease launches. We prioritize transparent communication, operational efficiency, and continuous improvement in all aspects of our service delivery.
Services
Specialty Pharmacy
Patient Services Hub
3PL Distribution
Reimbursement Programs
Clinical Assessment
Highlights and features
- We exclusively specialize in orphan drug commercialization for rare diseases
- Our integrated 3PL, hub, and specialty pharmacy model ensures seamless service
- 99% patient satisfaction ratings maintained over eight consecutive years
- Proven success in 10+ rare disease product launches with major pharmaceutical partners
- 24/7 pharmacy support combined with personalized patient care coordination
Associations and certifications
- VAWD
What people say
Smoothest launch experience
Exceeded expectations
High patient satisfaction
Irreplaceable partnership
Dedicated team efforts
Services
Specialty Pharmacy
Our dedicated specialty pharmacy provides comprehensive medication management for rare disease treatments. With disease-specific expertise and personalized patient support, we ensure proper medication handling, adherence monitoring, and direct patient counseling. Our pharmacists work closely with prescribers to maintain treatment continuity and address therapy-related challenges. The service includes customized patient education materials and 24/7 clinical support for urgent medication questions.
Patient Services Hub
This centralized hub manages all patient support services including insurance verification, prior authorization assistance, and financial aid programs. Our team coordinates care across multiple stakeholders while maintaining compliance with regulatory requirements. Services include personalized treatment plans, regular patient follow-ups, and adverse event monitoring to ensure optimal therapeutic outcomes for complex rare disease therapies.
3PL Distribution
Our licensed wholesale distribution network specializes in rare disease medications with strict chain-of-custody controls. The service includes real-time inventory tracking, temperature-controlled storage, and expedited shipping solutions. We maintain compliance with DSCSA regulations and provide serialization capabilities while eliminating common distribution challenges like channel stuffing and product loss in transit.
Reimbursement Programs
This service navigates complex insurance requirements for specialty medications through dedicated reimbursement specialists. We handle prior authorization processes, appeal submissions, and coverage verification across commercial, Medicare, and Medicaid plans. Our team works directly with patients and providers to minimize financial barriers and ensure timely access to critical rare disease treatments.
Clinical Assessment
Our clinical assessment program includes regular patient evaluations through nurse case managers to monitor treatment effectiveness and adherence. The service tracks key therapeutic metrics, manages adverse event reporting, and provides detailed outcome data to manufacturers. This proactive approach helps optimize treatment protocols and improve long-term patient outcomes for rare disease therapies.
People
Alan Erck
Chief Commercial Officer
With over 20 years in pharmaceutical commercialization, Alan leads Anovorx Group's strategic growth initiatives and manufacturer partnerships. He brings extensive experience in specialty pharmacy operations and rare disease market access solutions.
Susan Robinson
SVP, Business Development
As a licensed pharmacist with 25+ years in specialty pharmacy, Susan oversees business development and client relations. Her expertise includes rare disease therapy commercialization and integrated patient support program design.
Natalie Kelly
Vice President, Business Development & Marketing
Natalie manages strategic partnerships and marketing initiatives with 15+ years in orphan drug commercialization. She specializes in creating customized market access solutions for complex therapeutic areas.
Questions
What makes Anovorx Group different from other specialty pharmacies?
We exclusively focus on orphan drugs for rare diseases with an integrated model combining specialty pharmacy, patient hub services, and 3PL distribution under one roof.
How does Anovorx Group handle insurance and reimbursement challenges?
Our dedicated reimbursement team specializes in rare disease therapies, navigating complex insurance requirements and providing personalized support for patients and providers.
What patient support services are available?
We offer comprehensive services including prior authorization assistance, financial aid programs, personalized care coordination, and 24/7 clinical support for medication-related questions.
How does Anovorx Group ensure medication availability?
Our real-time inventory tracking and direct distribution model eliminate channel stuffing while maintaining strict chain-of-custody controls for rare disease medications.
What clinical support do you provide for manufacturers?
We offer outcome tracking, adverse event monitoring, and detailed reporting through our integrated platform to support post-launch commercial success.
Can Anovorx Group handle both new and existing orphan drug programs?
Yes, we specialize in launching new orphan drugs and seamlessly transitioning existing programs with minimal disruption to patient care.
Reviews (2)
Cary Miller
Jun 06, 2019
Report
I was leery of medicine delivered to my door, but my oncologist at West Cancer Clinic said his patients had had good experience with Anovo. And he was right. The ladies are always polite, precise, and friendly, and my medicines have arrived a few days later on the very day I indicate is good with me. This has worked out very well, and allowed me not to have to wait in pharmacy lines in my car or in person.
Desiree Miller
Dec 24, 2018
Report
I was told by my Oncologist that I would have to take a pill every day for 5 years to prevent my breast cancer from coming back. That wasn't the best news but I knew I had to comply with the doctor's orders. The ladies that called me to schedule my deliveries were awesome!! They were ALWAYS polite, friendly, precise and quick!! I knew that within a couple days I would receive my shipment. However, due to my insurance I had to switch to another mail order provider. My rx was e-scribed almost 2 weeks ago and I STILL don't have my meds!! I've been completely out since Monday. This is not good!! I
